Explore 3 Stock Ideas & Industry Insights Download Free Report

Premium

Biotech Capital Crunch Meets Clinical Momentum: SPRB, XRTX, BIOA, CGTX, CMND, ANAB & AKTX Signal Funding, Compliance and Pipeline Shifts in 2026

The small-cap biotechnology segment has entered a familiar yet finely balanced phase of the capital cycle. With equity markets selectively open, clinical catalysts regaining prominence, and regulatory compliance shaping near-term trajectories, a cluster of emerging companies is navigating the dual imperatives of funding and …

Nitish Kishor | 21 April 2026

NVIDIA Corporation - From Graphics Chips to the Engine of the AI Era

NVIDIA Corporation stands today as one of the most consequential technology companies in history — not merely because of its market capitalisation, which briefly surpassed $3 trillion in 2024, but because it has engineered the foundational infrastructure on which the artificial intelligence revolution runs. …

Nitish Kishor | 21 April 2026

US Sector Momentum Analysis: Tech Anchors the Market as Cyclical Value Attempts a Base

The US sector rotation on April 20, 2026, reveals a market in a state of highly localized structural repair. The Relative Rotation Graph (RRG) highlights a defining reality: while secular growth (led by mega-cap Tech) continues to effortlessly dominate the top of the board, …

Robert Luong | 20 April 2026

US Sector Performance Analysis: Cyclicals Regain Footing While Defensives Plunge

The US equity market session on April 20, 2026, showcased a subdued, fragmented, and highly rotational trading environment. Rather than a unified directional surge, institutional capital engaged in a quiet reshuffling—locking in recent gains from high-beta consumer and digital growth names to fund a …

Robert Luong | 20 April 2026

US Sector Performance Analysis: Discretionary Leads a Broad Rebound as Energy Collapses

The US equity market session on April 17, 2026, showcased a definitive "everything rally" right before the weekend, with one glaring exception. Institutional capital poured heavily back into the market, aggressively buying up beaten-down cyclicals, secular tech growth, and core defensives. The sheer breadth …

Robert Luong | 19 April 2026

US Sector Momentum Analysis: A Broad Structural Revival as Cyclicals and Consumer Sectors Catch a Bid

The US sector rotation on April 17, 2026, reveals a market attempting a massive, broad-based structural recovery. The Relative Rotation Graph (RRG) highlights a defining shift: while mega-cap tech continues to anchor the tape, a unified wave of cyclical, consumer, and real estate sectors …

Robert Luong | 19 April 2026

US Sector Performance Analysis: Energy Erupts and Tech Holds as Health Care Plunges

The US equity market session on April 16, 2026, was characterized by a highly erratic, fragmented rotation. Instead of a unified directional bias, capital flows fractured. Institutional investors aggressively squeezed beaten-down commodity sectors higher, maintained their premium bids for mega-cap tech, and executed a …

Robert Luong | 16 April 2026